Eli Lilly and Co. announced Thursday, Dec. 18 that its experimental daily GLP-1 pill, orforglipron, successfully helped patients maintain significant weight loss after they stopped using popular injectable treatments like Wegovy and Zepbound.
Read MoreWarsaw-based Zimmer Biomet, a global medical technology leader, today announced U.S. Food and Drug Administration, clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System that offers a more customized experience for surgeons to help deliver accurate and reproducible outcomes in robotic-assisted total knee replacement surgery.
Read MoreEli Lilly and Company and Adverum Biotechnologies, a clinical-stage gene therapy company aiming to preserve sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adverum and its lead product candidate, Ixo-vec.
Read MoreRoche has announced that the U.S. Food and Drug Administration has categorized its Ionify 25-Hydroxy Vitamin D total assay as “Moderate Complexity” under the Clinical Laboratory Improvement Amendments of 1988.
Read MoreA Seattle-based seafood company has expanded its recall of shrimp products sold nationwide because of potential radioactive contamination, federal officials said.
Read MoreEli Lilly and Company today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance.
Read MoreElanco Animal Health Incorporated announced the U.S. Food and Drug Administration has approved Zenreli, a highly effective and convenient once-daily oral JAK inhibitor for control of itching associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Read MoreThe U.S. Food and Drug Administration is alerting health care providers and facilities to stop using NIM Contact EMG Reinforced Endotracheal Tubes and NIM (Standard) EMG Reinforced Endotracheal Tubes by Medtronic.
Read MoreThe U.S. Food and Drug Administration approved Eli Lilly and Company’s Zepbound injection, the first and only obesity treatment of its kind that activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 hormone receptors.
Read MoreThe U.S. Food and Drug Administration on Monday approved the latest round of COVID-19 boosters, as public health officials brace for another cold and flu season.
Read MoreManchester University students and faculty in the pharmacogenomics, or PGx, program are taking an active role in maintaining a nationwide database that cross-references drug-gene interaction information in clinical guidelines with U.S. Food and Drug Administration data.
Read MoreZimmer Biomet and Canary Medical jointly announced the U.S. Food and Drug Administration has cleared the way for marketing of the world’s first and only smart knee for total knee replacement surgery.
Read MoreZimmer Biomet announced the U.S. Food and Drug Administration has approved clearance of the ROSA Hip System for robotically-assisted direct anterior total hip replacement.
Read MoreKroger Health, the healthcare division of The Kroger Co.announced on Tuesday it will provide the COVID-19 vaccine nationwide across its 2,200 pharmacies and 220 clinics, partnering with the federal government and state health departments to administer the vaccine in accordance with the rollout plan.
Read More
